Free/total serum prostate-specific antigen ratio: How helpful is it in detecting prostate cancer?

British Journal of Urology

Volumn 81, Issue 3, 1998, Pages 419-423

  Masters, J G ^a,b   Keegan, P E ^b   Hildreth, A J ^a   Greene, D R J ^b  

^a Departments of Urology   (United Kingdom)

^b CITY HOSPITALS SUNDERLAND NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Prostate cancer; PSA ratio; Total prostate specific antigen level

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; RECEIVER OPERATING CHARACTERISTIC; TRANSRECTAL ULTRASONOGRAPHY; TRANSURETHRAL RESECTION;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BIOPSY; FALSE POSITIVE REACTIONS; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 0031819559     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1998.00566.x     Document Type: Article

References (16)

1. Buck CA. Prostate Cancer Question And Answers. 1st edn. Chapt 1. Merit Publishing International, 1995; 10-9
2. Oesterling JE, Jacobsen SJ, Chute CG et al. Serum prostatespecific antigen in a community based population of healthy men: establishment of age-specific reference ranges. JAMA 1993; 270: 860-4
3. Oesterling JE, Jacobsen SJ, Klee GG et al. Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios. J Ural 1995; 154: 1090-5
4. McCormack RT, Rittenhouse HG, Finlay JA et al. Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology 1995; 45: 729-44
5. Catalona WJ, Smith DS, Wolfert RL et al. Evaluation of percentage of free serum prostatic specific antigen to improve specificity of prostate cancer screening. JAMA 1995; 274: 1214-20
6. Luderer AA, Chen YT, Soriano TF et al. Measurement of the proportion of free to total prostate specific antigen improves the diagnostic performance of prostate specific antigen in the diagnostic grey zone of total prostate specific antigen. Urology 1995; 46: 187-94
7. Filella X, Alcover J, Molina R et al. Clinical usefulness of free psa fraction as an indicator of prostate cancer. Int J Cancer 1995; 63: 780-4
8. Vashi AR, Wojno KJ, Henricks W et al. Determination of the 'reflex range' and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostate evaluation using the AxSYM system. Urology 1997; 49: 19-27
9. Bangma CH, Kranse R, Blijenberg BG. Schroder FH. The value of screening tests in the detection of prostate cancer. Part II: retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges and PSA density. Urology 1995; 46: 779-84
10. Chen Y-T, Luderer AA, Thiel RP, Carlson G. Cuny CL, Soriano TF. Using proportions of free to total prostate-specific antigen to predict the probability of prostate cancer. Urology 1996; 47: 518-24
11. Higashihara E, Nutahara K, Kojima M et al. Significance of serum prostate specific antigen in the screening of prostate cancer. J Urol 1996; 156: 1964-8
12. Froschermaier SE, Pilarsky CP, Wirth MP. Clinical significance of the determination of noncomplexed prostate-specific antigen as a marker for prostate carcinoma. Urology 1996; 47: 525-8
13. Catalona WJ, Colberg JW, Smith DS. Ornstein DK. Shayka JJ. Measurement of percent-free psa improves specificity for low PSA cutoffs in prostate cancer screening. J Urol 1996; 155: 422A, Abs 450
14. Wolff JM, Borchers H, Effert PJ, Habib FK, Jaske G. Free-to-total prostate-specific antigen serum concentrations in patients with prostate cancer and benign prostatic hyperplasia. Br J Urol 1996; 78: 409-13
15. Prestigiacomo AF, Lilja H, Petterson K, Wolfert RL, Stamey TAA. Comparison of the free fraction antigen in men with benign and cancerous prostates: the best case scenario. J Urol 1996; 156: 350-4
16. Brawer MK. Editorial comment. J Urol 1996; 156: 354